---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-001906"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2025-12-17T23:59:59+00:00"
generated_at: "2026-05-16T12:57:17.788511+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Pelthos Therapeutics shareholders elect directors, approve waiver of convertible note share limit, ratify auditor

## Summary
- All seven director nominees elected with >2.24M 'For' votes each; broker non-votes of 278,134.
- Shareholders approved waiver of share issuance limit under senior secured convertible notes (For 2,247,248, Against 3,474).
- Ratified CBIZ CPAs as independent auditor for fiscal year ending Dec 31, 2025 (For 2,509,765, Against 19,091).

## SEC filing metadata
- accession: 0001753926-25-001906
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2025-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001906/0001753926-25-001906-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001906/g085048_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-001906
- JSON: https://secwatch.observer/filing/0001753926-25-001906.json
- Plain text: https://secwatch.observer/filing/0001753926-25-001906.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.